Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by _mvmon Mar 01, 2019 10:27am
91 Views
Post# 29428448

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Where’s the pricing story coming from?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Where’s the pricing story coming from?Yeah, I am pretty well done being enthusiastic about this story. Time to look for a good exit point. Today is not the day. Yeah, they will shed probably at least 25% on this bonehead move. Nope, no idea why or how the situation got so desperate that they had to resort to this.
And yeah, whoever that PR guy was that they hired; please, that is simply too much incompetence...

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities